Product Information
LIOTHYRONINE SOD 5 MCG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2023 per EA under NDC 59762120601. Its NADAC has been published 393 times since Mar 27, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 ug/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762120601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LIOTHYRONINE SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA010379FDA Approved
Before 1982
TE Code
AB
On Market Since
2/6/2019
Pharmacological Classes
Price Statistics
The NADAC for LIOTHYRONINE SOD 5 MCG TAB has been published 393 times since Mar 27, 2019, and over the history we have for it it has declined 65.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2023 per EA |
|---|---|
| All-time high | $0.6537 (May 15, 2019) |
| All-time low | $0.1898 (Nov 20, 2024) |
| 52-week high | $0.2578 |
| 52-week low | $0.2023 |
| Median price | $0.3240 |
| Average price | $0.3712 |
| Largest weekly change | -24.0% (Apr 17, 2024) |
| Weeks tracked | 393 |
| Tracking since | Mar 27, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
liothyronine sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
l-Triiodothyronine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIOTHYRONINE SOD 5 MCG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LIOTHYRONINE SOD 5 MCG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.2023 per EA (NDC 59762120601), effective Sep 30, 2026.
How has the price of LIOTHYRONINE SOD 5 MCG TAB changed over time?
Over the history we have for it, the NADAC for LIOTHYRONINE SOD 5 MCG TAB has declined 65.1%. It has been tracked across 393 weekly CMS publications since Mar 27, 2019.
What are the highest and lowest recorded NADAC prices for LIOTHYRONINE SOD 5 MCG TAB?
Since Mar 27, 2019, the NADAC for LIOTHYRONINE SOD 5 MCG TAB has ranged from a low of $0.1898 (Nov 20, 2024) to a high of $0.6537 (May 15, 2019), with a median of $0.3240 per EA.
Are there cheaper alternatives to LIOTHYRONINE SOD 5 MCG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LIOTHYRONINE SOD 5 MCG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LIOTHYRONINE SOD 5 MCG TAB?
LIOTHYRONINE SOD 5 MCG TAB (NDC 59762120601) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.